Cleared Traditional

GASTRIN 34 HORMONE BY RADIOUMMUNOASSAY (K842079) - FDA 510(k) Clearance

Class I Chemistry device.

K842079 · Immuno Nuclear Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1984
Decision
34d
Days
Class 1
Risk

K842079 is an FDA 510(k) clearance for the GASTRIN 34 HORMONE BY RADIOUMMUNOASSAY. Classified as Radioimmunoassay, Gastrin (product code CGC), Class I - General Controls.

Submitted by Immuno Nuclear Corp. (Mchenry, US). The FDA issued a Cleared decision on June 26, 1984 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1325 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Immuno Nuclear Corp. devices

Submission Details

510(k) Number K842079 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 1984
Decision Date June 26, 1984
Days to Decision 34 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 88d · This submission: 34d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CGC Radioimmunoassay, Gastrin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1325
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.